Objective: To describe the characteristics of children treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in France. Design: Cross-sectional national survey. Setting: Paediatric CPAP/NIV teams of 28 tertiary university hospitals in France. Patients: Children aged <20 years treated with CPAP/NIV since at least 3 months on June 1st, 2019. Intervention: An anonymous questionnaire was filled in for every patient. Results: The data of 1447 patients (60% boys), mean age 9.8 ± 5.8 years were analysed. The most frequent underlying disorders were: upper airway obstruction (46%), neuromuscular disease (28%), disorder of the central nervous system (13%), cardiorespiratory disorder (7%), and congenital bone disease (4%). Forty-five percent of the patients were treated with CPAP and 55% with NIV. Treatment was initiated electively for 92% of children, while 8% started during an acute illness. A poly(somno)graphy (P(S)G) was performed prior to treatment initiation in 26%, 36% had a P(S)G with transcutaneous carbon dioxide monitoring (PtcCO2), while 23% had only a pulse oximetry (SpO2) with PtcCO2 recording. The decision of CPAP/NIV initiation during an elective setting was based on the apnea-hypopnea index (AHI) in 41% of patients, SpO2 and PtcCO2 in 25% of patients, and AHI with PtcCO2 in 25% of patients. Objective adherence was excellent with a mean use of 7.6 ± 3.2 h/night. Duration of CPAP/NIV was 2.7 ± 2.9 years at the time of the survey. Conclusion: This survey shows the large number of children treated with long term CPAP/NIV in France with numerous children having disorders other than neuromuscular diseases.
Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study / Fauroux, B., Khirani, S., Amaddeo, A., Massenavette, B., Bierme, P., Taytard, J., Stremler, N., Baravalle-Einaudi, M., Mazenq, J., Ioan, I., Schweitzer, C., Lampin, M.e., Binoche, A., Mordacq, C., Bergounioux, J., Mbieleu, B., Rubinsztajn, R., Sigur, E., Labouret, G., Genevois, A., et al.. - In: RESPIRATORY MEDICINE. - ISSN 1745-0454. - ELETTRONICO. - 181:(2021), pp. 106388."-"-106388."-". [10.1016/j.rmed.2021.106388]
Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study
Amaddeo A;
2021-01-01
Abstract
Objective: To describe the characteristics of children treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in France. Design: Cross-sectional national survey. Setting: Paediatric CPAP/NIV teams of 28 tertiary university hospitals in France. Patients: Children aged <20 years treated with CPAP/NIV since at least 3 months on June 1st, 2019. Intervention: An anonymous questionnaire was filled in for every patient. Results: The data of 1447 patients (60% boys), mean age 9.8 ± 5.8 years were analysed. The most frequent underlying disorders were: upper airway obstruction (46%), neuromuscular disease (28%), disorder of the central nervous system (13%), cardiorespiratory disorder (7%), and congenital bone disease (4%). Forty-five percent of the patients were treated with CPAP and 55% with NIV. Treatment was initiated electively for 92% of children, while 8% started during an acute illness. A poly(somno)graphy (P(S)G) was performed prior to treatment initiation in 26%, 36% had a P(S)G with transcutaneous carbon dioxide monitoring (PtcCO2), while 23% had only a pulse oximetry (SpO2) with PtcCO2 recording. The decision of CPAP/NIV initiation during an elective setting was based on the apnea-hypopnea index (AHI) in 41% of patients, SpO2 and PtcCO2 in 25% of patients, and AHI with PtcCO2 in 25% of patients. Objective adherence was excellent with a mean use of 7.6 ± 3.2 h/night. Duration of CPAP/NIV was 2.7 ± 2.9 years at the time of the survey. Conclusion: This survey shows the large number of children treated with long term CPAP/NIV in France with numerous children having disorders other than neuromuscular diseases.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0954611121000949-main.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
551.66 kB
Formato
Adobe PDF
|
551.66 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


